Loading...
MedX Health Corp
MDXHF•PNK
Healthcare
Medical - Devices
$0.001
$-0.00(-0.00%)
MedX Health Corp (MDXHF) Financial Performance & Income Statement Overview
Review MedX Health Corp’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
7.37%
↑ 7.37%
Operating Income Growth
23.84%
↑ 23.84%
Net Income Growth
20.25%
↑ 20.25%
Operating Cash Flow Growth
0.00%
Operating Margin
-557.53%
↓ 557.53%
Gross Margin
42.50%
↑ 42.50%
Net Profit Margin
-875.08%
↓ 875.08%
ROE
48.89%
↑ 48.89%
ROIC
32.96%
↑ 32.96%
MedX Health Corp (MDXHF) Income Statement & Financial Overview
Review MedX Health Corp's (MDXHF) income statement with detailed quarterly and annual figures.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $188039.00 | $90609.00 | $104301.00 | $106749.00 |
| Cost of Revenue | $114872.00 | $56528.00 | $49236.00 | $82408.00 |
| Gross Profit | $73167.00 | $34081.00 | $55065.00 | $24341.00 |
| Gross Profit Ratio | $0.39 | $0.38 | $0.53 | $0.23 |
| R&D Expenses | $133049.00 | $125551.00 | $124450.00 | $143226.00 |
| SG&A Expenses | $213832.00 | $308990.00 | $575207.00 | $631434.00 |
| Operating Expenses | $403247.00 | $521132.00 | $791369.00 | $774660.00 |
| Total Costs & Expenses | $518119.00 | $577660.00 | $840605.00 | $857068.00 |
| Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest Expense | $775794.00 | $206938.00 | $190102.00 | $176382.00 |
| Depreciation & Amortization | $11704.00 | $11704.00 | $11704.00 | $11704.00 |
| EBITDA | -$318376.00 | -$475347.00 | -$724600.00 | -$738615.00 |
| EBITDA Ratio | -$1.69 | -$5.25 | -$6.95 | -$6.92 |
| Operating Income | -$330080.00 | -$487051.00 | -$736304.00 | -$750320.00 |
| Operating Income Ratio | -$1.76 | -$5.38 | -$7.06 | -$7.03 |
| Other Income/Expenses (Net) | -$775794.00 | -$206938.00 | -$190102.00 | -$176382.00 |
| Income Before Tax | -$1.11M | -$693989.00 | -$926406.00 | -$926701.00 |
| Income Before Tax Ratio | -$5.88 | -$7.66 | -$8.88 | -$8.68 |
| Income Tax Expense | $0.00 | $0.00 | $0.00 | -$4.00 |
| Net Income | -$1.11M | -$693989.00 | -$926406.00 | -$926701.00 |
| Net Income Ratio | -$5.88 | -$7.66 | -$8.88 | -$8.68 |
| EPS | -$0.004 | -$0.003 | -$0.004 | -$0.004 |
| Diluted EPS | -$0.004 | -$0.003 | -$0.004 | -$0.004 |
| Weighted Avg Shares Outstanding | $266.72M | $264.66M | $264.66M | $261.96M |
| Weighted Avg Shares Outstanding (Diluted) | $266.72M | $264.66M | $264.66M | $261.96M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan